Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Robert A. Mittra (ORCID: https://orcid.org/0000-0001-8418-7340)
- Colin A. McCannel (ORCID: https://orcid.org/0000-0003-0774-6414)
- Philip Jaycock
- Hajir Dadgostar
- Margaret Chang
- Jeremy D. Wolfe (ORCID: https://orcid.org/0000-0003-2781-7152)
- Ashwini Bobbala
- Shamika Gune (ORCID: https://orcid.org/0000-0001-9963-5652)
- David Eichenbaum (ORCID: https://orcid.org/0000-0003-0654-0668)
- Galin Spicer
- Mark Michels
- Natalia F. Callaway (ORCID: https://orcid.org/0000-0002-9788-9605)
- William R. Freeman
- Victoria C Beindl
- Nauman Chaudhry
- Logan Brooks
Institutions
- Roche (Switzerland) (CH)
- University of California, Los Angeles (US)
- Oakland University (US)
- Yale University (US)
- University of California San Diego (US)
- California Retina Consultants (US)
- Doheny Eye Institute (US)
- Associated Retinal Consultants (US)
- Retina Care Specialists (US)
- Roche (United Kingdom) (GB)
- Retina Associates of Florida (US)
- New England Retina Associates (US)
- Retina Vitreous Associates of Florida (US)
- Smith-Kettlewell Eye Research Institute (US)
- Retina Partners (US)
Publication Details
- Journal
- Ophthalmology Retina
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1016/j.oret.2024.08.005
- Citations
- 5
- Primary Topic
- Ocular Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- Roche
- Genentech